Return to search

When Should a Provider Consider Insulin Human Inhalation Powder?

Insulin human inhalation powder, a rapid-acting inhaled insulin, was approved by the FDA in June 2014 for patients with type 1 or type 2 diabetes. For patients reluctant to start insulin therapy because of fear of injections, insulin human inhalation powder may be an alternative. This article discusses appropriate dosing, use, and monitoring.

Identiferoai:union.ndltd.org:ETSU/oai:dc.etsu.edu:etsu-works-16371
Date01 May 2016
CreatorsMospan, Cortney M., Leonard, Chelsea, Alley, Kelli
PublisherDigital Commons @ East Tennessee State University
Source SetsEast Tennessee State University
Detected LanguageEnglish
Typetext
SourceETSU Faculty Works

Page generated in 0.0022 seconds